Adeshwar Meditex Limited has submitted to the Exchange Disclosure under Regulation 74(5) of SEBI (DP) Regulations, 2018, as amended, received from Bigshare Services Pvt Ltd (RTA) for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adeshwar Meditex Limited has submitted a regulatory disclosure to BSE under SEBI Regulation 74(5), received from its Registrar and Transfer Agent (RTA), Bigshare Services Pvt. Ltd. The disclosure certifies that no dematerialisation requests for equity shares were received during the period January 1, 2026 to March 31, 2026. This is a routine compliance filing confirming nil demat activity for the quarter. The filing is signed digitally by Director Krishnojirao Nagaraja Rao and dated April 8, 2026.
This is a standard regulatory confirmation with no direct impact on the stock. It indicates normal share registry operations with no unusual dematerialisation activity during the quarter.